PURPL Represses Radiation‐Induced Apoptosis to Promote Radioresistance in Cutaneous Melanoma by Direct Interfering With BID Cleavage
Pigment Cell & Melanoma Research · 2025
DOI: 10.1111/pcmr.70018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pigment Cell & Melanoma Research, 2025. Verfasst von Xue Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Immunology, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Melanoma, Apoptosis, Radiation Tolerance, Skin Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Guangdong Medical Research Foundation, Science and Technology Projects in Guangzhou, Medical and Health Own Fund Guiding Project of Zigong Academy of Medical Sciences.
Abstract (Originalsprache)
The rise of radioresistance in treating cutaneous melanoma challenges the efficacy of radiotherapy. Transcriptomic sequencing highlights PURPL as one of the top upregulated long noncoding RNAs in response to ionizing radiation (IR) treatment in melanoma cells, suggesting its role in radioresistance. To explore such hypothesis, loss‐of‐function experiments were conducted to assess the impact of PURPL on melanoma cell viability, colony formation, and migration. Mechanistic studies using RNA pulldown identified BID as the interacting protein partner of PURPL. Further analysis explored the relationship among PURPL, BID, and Caspase‐8 in the context of IR‐induced DNA damage and apoptosis through loss‐of‐ and gain‐of‐function experiments. The findings demonstrated that silencing PURPL significantly repressed melanoma cell viability, colony formation, migration, and invasiveness, indicating its potential role in promoting radioresistance. Moreover, PURPL was shown to repress IR‐induced DNA damage and apoptosis, supporting its involvement in melanoma radioresistance. Mechanistically, PURPL inhibited the interaction between BID and Caspase‐8, thereby modulating the mitochondrial apoptosis pathway and promoting radioresistance. In conclusion, this study provides evidence supporting the pro‐radioresistance role of PURPL in melanoma. In vivo assays further corroborated the in vitro findings, highlighting the potential clinical relevance of targeting PURPL in radioresistant melanoma. By interfering with the association between BID and Caspase‐8, PURPL may serve as a novel therapeutic target for clinical radiotherapy during the treatment of melanoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Molecular Immunology, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.
- Department of Clinical Medical Technology, Sichuan Vocational College of Health and Rehabilitation, Zigong, China.
- Department of Toxicology, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, China.
- Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangdong, China.
ORCID-Profile: Liang Zhou
Förderung
- Guangdong Medical Research Foundation
- Science and Technology Projects in Guangzhou
- Medical and Health Own Fund Guiding Project of Zigong Academy of Medical Sciences
- Basic and Applied Basic Research Foundation of Guangdong Province
- National Natural Science Foundation of China
Zitieren
APA
Li, X., Han, S., Liang, X., Liu, J., Wang, K., Jin, Y., Zhang, C., Xu, M., Liu, J., Ma, L., & Zhou, L. (2025). PURPL Represses Radiation‐Induced Apoptosis to Promote Radioresistance in Cutaneous Melanoma by Direct Interfering With BID Cleavage. Pigment Cell & Melanoma Research. https://doi.org/10.1111/pcmr.70018
Vancouver
Li X, Han S, Liang X, Liu J, Wang K, Jin Y, et al. PURPL Represses Radiation‐Induced Apoptosis to Promote Radioresistance in Cutaneous Melanoma by Direct Interfering With BID Cleavage. Pigment Cell & Melanoma Research. 2025. doi:10.1111/pcmr.70018
BibTeX
@article{Li2025,
author = {Li, Xue and Han, Shuo and Liang, Xiaoting and Liu, Jieyu and Wang, Ke and Jin, Yi and Zhang, Chunting and Xu, Minna and Liu, Jiabin and Ma, Li and Zhou, Liang},
title = {PURPL Represses Radiation‐Induced Apoptosis to Promote Radioresistance in Cutaneous Melanoma by Direct Interfering With BID Cleavage},
journal = {Pigment Cell & Melanoma Research},
year = {2025},
doi = {10.1111/pcmr.70018}
}
EUVIMED